182 related articles for article (PubMed ID: 20852595)
1. Stem cell markers (cytokeratin 15, cytokeratin 19 and p63) in in situ and invasive cutaneous epithelial lesions.
Abbas O; Richards JE; Yaar R; Mahalingam M
Mod Pathol; 2011 Jan; 24(1):90-7. PubMed ID: 20852595
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease.
Fernandez-Flores A
Ann Diagn Pathol; 2016 Feb; 20():1-6. PubMed ID: 26740287
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
4. [Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin].
Majores M; Bierhoff E
Pathologe; 2015 Feb; 36(1):16-29. PubMed ID: 25663185
[TBL] [Abstract][Full Text] [Related]
5. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
[TBL] [Abstract][Full Text] [Related]
6. P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma.
Oh CW; Penneys N
Am J Dermatopathol; 2004 Feb; 26(1):22-6. PubMed ID: 14726819
[TBL] [Abstract][Full Text] [Related]
7. Bowenoid papulosis. Classification as a low-grade in situ carcinoma of the epidermis on the basis of histomorphologic and DNA ploidy studies.
Böcking A; Chatelain R; Salterberg A; Hagedorn M; Gross G
Anal Quant Cytol Histol; 1989 Dec; 11(6):419-25. PubMed ID: 2604822
[TBL] [Abstract][Full Text] [Related]
8. Data Independent Acquisition Proteomic Analysis Can Discriminate between Actinic Keratosis, Bowen's Disease, and Cutaneous Squamous Cell Carcinoma.
Azimi A; Yang P; Ali M; Howard V; Mann GJ; Kaufman KL; Fernandez-Penas P
J Invest Dermatol; 2020 Jan; 140(1):212-222.e11. PubMed ID: 31254517
[TBL] [Abstract][Full Text] [Related]
9. S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care.
Heppt MV; Leiter U; Steeb T; Alter M; Amaral T; Bauer A; Bechara FG; Becker JC; Breitbart EW; Breuninger H; Diepgen T; Dirschka T; Eigentler T; El Gammal AKS; Felcht M; Flaig MJ; Follmann M; Fritz K; Grabbe S; Greinert R; Gutzmer R; Hauschild A; Hillen U; Ihrler S; John SM; Kofler L; Koelbl O; Krause-Bergmann A; Kraywinkel K; Krohn S; Langer T; Loquai C; Löser CR; Mohr P; Nashan D; Nothacker M; Pfannenberg C; Salavastru C; Schmitz L; Stockfleth E; Szeimies RM; Ulrich C; Voelter-Mahlknecht S; Vordermark D; Weichenthal M; Welzel J; Wermker K; Wiegand S; Garbe C; Berking C
J Dtsch Dermatol Ges; 2023 Oct; 21(10):1249-1262. PubMed ID: 37845077
[TBL] [Abstract][Full Text] [Related]
10. Expression of p63 and cyclooxygenase-2 and their correlation in skin tumors.
Wu Y; Liu H; Li J
J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):206-8. PubMed ID: 17497299
[TBL] [Abstract][Full Text] [Related]
11. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
[TBL] [Abstract][Full Text] [Related]
12. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
Wrone DA; Yoo S; Chipps LK; Moy RL
Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
[TBL] [Abstract][Full Text] [Related]
13. Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.
Riihilä PM; Nissinen LM; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
J Invest Dermatol; 2014 Feb; 134(2):498-506. PubMed ID: 23938460
[TBL] [Abstract][Full Text] [Related]
14. p16INK4a expression in actinic keratosis and Bowen's disease.
Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
Bordbar A; Dias D; Cabral A; Beck S; Boon ME
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of cytokeratin 15, cytokeratin 19, follistatin, and Bmi-1 in basal cell carcinoma.
Kim HC; Sohng SH; Shin DH; Choi JS; Bae YK
Int J Dermatol; 2016 Jan; 55(1):36-44. PubMed ID: 26739632
[TBL] [Abstract][Full Text] [Related]
17. Squamous-cell carcinoma in situ is a fiction!
Ackerman AB; Mones J
J Cutan Pathol; 2009 Jan; 36(1):74-5; author reply 76. PubMed ID: 19125737
[No Abstract] [Full Text] [Related]
18. Different Immunohistochemical Localization of Fatty Acid Binding Protein 5 in Actinic Keratosis Compared with That in Bowen's Disease: A Retrospective Study.
Ahn B; Kim CH; Chae YS; Lee JH; Lee Y; Ahn HH; Lee YJ
Am J Dermatopathol; 2021 May; 43(5):356-361. PubMed ID: 33055535
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Foxp3 positive T regulatory cells is increased during progression of cutaneous squamous tumors.
Jang TJ
Yonsei Med J; 2008 Dec; 49(6):942-8. PubMed ID: 19108017
[TBL] [Abstract][Full Text] [Related]
20. Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease.
Mai KT; Alhalouly T; Landry D; Stinson WA; Perkins DG; Yazdi HM
Histopathology; 2002 Oct; 41(4):331-6. PubMed ID: 12383215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
